Olema Pharmaceuticals, Inc. OLMA Free cash flow
Discontinued — last reported Q3 '25
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Olema Pharmaceuticals, Inc.’s reported figures.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s free cash flow?
- Olema Pharmaceuticals, Inc. (OLMA) reported free cash flow of -$34.53M in Q3 2025.
- How has Olema Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Olema Pharmaceuticals, Inc.'s free cash flow decreased by 27.8% year-over-year, from -$27.02M to -$34.53M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s free cash flow?
- Over 2 years (2021 to 2024), Olema Pharmaceuticals, Inc.'s free cash flow has grown at a 41.4% compound annual growth rate (CAGR), from -$52.27M to -$104.51M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.